✦ LIBER ✦

Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer

✍ Scribed by Leonard Saltz; Suprith Badarinath; Shaker Dakhil; Bryan Bienvenu; W. Graydon Harker; George Birchfield; Laurence K. Tokaz; David Barrera; Paul R. Conkling; Mark A. O'Rourke; Donald A. Richards; Diane Reidy; David Solit; Efsevia Vakiani; Marinella Capanu; Amy Scales; Feng Zhan; Kristi A. Boehm; Lina Asmar; Allen Cohn

Book ID: 116365625
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 512 KB
Volume: 11
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2011.05.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Trial of Oxaliplatin, Infusional

Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer

✍ Wells A. Messersmith; Antonio Jimeno; Heather Jacene; Ming Zhao; Piotr Kulesza; 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 305 KB

Phase III Multicenter Randomized Clinica

Phase III Multicenter Randomized Clinical Trial to Evaluate the Safety and Efficacy of CoFactor®/5-Fluorouracil/Bevacizumab Versus Leucovorin/5-Fluorouracil/Bevacizumab as Initial Treatment for Metastatic Colorectal Carcinoma

✍ Muhammad Wasif Saif; James Merritt; Joan Robbins; Jeffrey Stewart; Joachim Schup 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 126 KB

Front-line Bevacizumab in combination wi

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

✍ Christos Emmanouilides; Georgia Sfakiotaki; Nikolaos Androulakis; Kostas Kalbaki 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 263 KB

Bevacizumab Improves the Efficacy of 5-F

Bevacizumab Improves the Efficacy of 5-Fluorouracil/Leucovorin in Patients with Advanced Colorectal Cancer

✍ Nancy Price; Edward Chu; Vinay K. Jain 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 90 KB

Addition of Bevacizumab to Bolus Fluorou

Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial

✍ Kabbinavar, F. F. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 533 KB

150 Molecular tumor characteristics and

150 Molecular tumor characteristics and response to bevacizumab plus irinotecan/5-fluorouracil/leucovorin in metastatic colorectal cancer

✍ H. Koeppen; W. Ince; E. Holmgren; M. Zhang; P. Tobin; R. Zhang; W. Novotny; K. H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 134 KB